Trademarkia Logo

Canada

C$
REMSEQ
FORMALIZED

on 2 Oct 2024

Last Applicant/ Owned by

Remix Therapeutics Inc.

400 Technology SquareCambridge MA 02139

US

Serial Number

2353319 filed on 25th Mar 2024

Correspondent Address

MOFFAT & CO.

P.O. Box 2088, Station DOttawa

ONTARIO

CA

K1P5W3

REMSEQ

Trademark usage description

pharmaceutical preparations for the treatment of genetic disorders, immune system related diseases and disorders, metabolic diseases and disorders, he Read More

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of genetic disorders, immune system related diseases and disorders, metabolic diseases and disorders, hematological diseases and disorders, cancer, neurological diseases and disorders, reproductive diseases and disorders, gynecological diseases and disorders, inflammatory diseases and disorders, cardiological diseases and disorders, respiratory diseases and disorders, gastroenterological diseases and disorders, musculoskeletal diseases and disorders, ophthalmological diseases and disorders, and dermatological diseases and disorders; gene therapy preparations for the treatment of genetic disorders, immune system related diseases and disorders, metabolic diseases and disorders, hematological diseases and disorders, cancer, neurological diseases and disorders, reproductive diseases and disorders, gynecological diseases and disorders, inflammatory diseases and disorders, cardiological diseases and disorders, respiratory diseases and disorders, gastroenterological diseases and disorders, musculoskeletal diseases and disorders, ophthalmological diseases and disorders, and dermatological diseases and disorders; preparations for detecting mutation in RNA genes for medical purposes.


Classification kind code

12

Class [042]
Development of gene-based medicines; gene therapy and modulation research; laboratory research in the field of degrading and enhancing RNA including exon skipping and rescue genetic lesions; medical and scientific research in the fields of genetics, genomics, gene modulation and genetic engineering; DNA and RNA analysis and sequencing services for scientific and research purposes; research, development and scientific consultancy in the field of genomics and gene modulation.


Classification kind code

12

Mark Details


Serial Number

2353319

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 48
on 14th Feb 2025
Agent Changed
Submitted for opposition 257
on 3rd Oct 2024
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 2th Oct 2024
Created
Submitted for opposition 31
on 2th Oct 2024
Formalized
Submitted for opposition 30
on 25th Mar 2024
Filed
Submitted for opposition 228
on 25th Mar 2024
International Registration